Clinical & Surgical Translation of Adult Stem Cells

Agenda Topics

• Bone Marrow-derived Stem Cells for Clinical Applications
• Cell Banking and Cellular Cryopreservation
• Disease Classes Addressed and Current Status of Ongoing Clinical Trials with Adult Stem Cells
• Exosomes as a Means of Communication Mediated by Adult Stem Cells
• Plastic and Reconstructive Surgery and Cosmetic Applications
• Platelet Rich Plasma (PRP) and its Clinical Utility
• Regulatory Landscape and Ethical Considerations
• Stromal Vascular Fraction (SVF) derived from Adipose Tissue and its Clinical Utility and Current Deployment
• Case Studies with SVF
• Clinical Effects of Mesenchymal Stem Cells (MSCs) Derived from Adipose Tissue
• SVF Harvest Hands-on Clinical Practicum
• Surgical Scaffolds and Tissue Engineering
• Technologies for Cell Expansion ex vivo
• Translational Research Activities with Adult Stem Cells
• Autoimmune/Inflammation
• Cardiovascular
• Dermatology
• Neurology
• Opthalmology
• Orthopaedic Applications
• Urological Applications
• Wound Healing

Sponsorship and Exhibition Opportunities

Jeff Fan, Exhibition Manager
jeff@selectbioconferences.com
+1-510-857-4865

Confirmed Speakers to date

Ahmed Al-Qahtani, Assistant Professor, UAE University, College of Medicine and Health Sciences
David Angeloni, Chief Science Officer, Millennium Medical Technologies Inc
John Arnone, Chairman & CEO, American CryoStem
Mark Berman, Past President, American Academy of Cosmetic Surgery; Medical Director, California Stem Cell Treatment Center
Nathan Bryan, Professor, Baylor College of Medicine
Gregorio Chazenbalk, Research Associate, Dept of Obstetrics and Gynecology, University of California-Los Angeles
Kristin Comella, Chief Scientific Officer, Bioheart, Inc.
Jyothi Devakumar, Principal Consultant, Evolvis Consulting, Singapore
Chris Duma, Brain Surgeon Specialist, Hoag Neurosciences Institute
Paul Gatenholm, Professor, Director of 3D Bioprinting Center, Chalmers University of Technology, Sweden; CEO, CELLHEAL AS, Norway
Steven Gitt, Medical Director, North Valley Plastic Surgery & Phoenix Stem Cell Treatment Center
Peter Hanson, President, San Diego Stem Cell Treatment Center
Robert Harman, CEO, CSO, VetStem Biopharma, Inc
Barbara Krutchkoff, Director of Scientific Affairs, Lipogems; CEO, A3Cell
Elliot Lander, Medical Director, California Stem Cell Treatment Center
Hee Young Lee, Surgeon, Baroyl Plastic Surgery, Medikan Co., South Korea
Oren Levy, Instructor of Medicine, Harvard Medical School/Brigham and Women’s Hospital
Dennis Lox, Physician, Florida Spine and Sports Medicine Center
Todd Malan, Medical Director, Center for Regenerative Cell Medicine
Lewis J. Obi, Medical Director, Cell Surgical Network of Florida; Medical Director of Obi Plastic Surgery Clinic
Ken Pettine, Fellowship Trained Spine Surgeon, Premier Stem Cell Institute
Andrew Pope, Co-Medical Director , Kansas Regenerative Medicine Center
Joseph Purita, Medical Director of Stem Cell Centers of America, Institute Of Regenerative and Molecular Orthopedics
Ron Shane, Medical and Research Director, Millennia Concepts Biotech, LLC/American Academy of Anti-aging Medicine
Ming-Sing Si, Assistant Professor of Cardiac Surgery, Department of Cardiac Surgery, University of Michigan
Aladar Szalay, Professor, University of Würzburg
Jessica Valdez, Certified Surgical Technologist, California Stem Cell Treatment Center/Cell Surgical Network
Wen Wang, Director of Medical Research, Cellular Biomedicine Group Ltd.
Allan Wu, Clinical Adjunct Professor, University of California-Riverside Stem Cell Research Center; Director of Cosmetic, Reconstructive and Regenerative Surgery, Revive Wellness Centers

This Conference and Associated Clinical Practicum is Ideally Suited for the Following Audiences:

• Basic Researchers Seeking to Drive their Innovations towards Translational/Clinical Applications
• Clinician-Scientists
• Cosmetic Surgeons, Surgeons Seeking to Understand the Regenerative Medicine/Stem Cells Space and the Clinical Utilization of Adult Stem Cells in a Regulatory-Compliant Manner in their Clinical Practice
  
• Attorneys, Investors, Regulatory Agency Professionals Seeking Clarity in the Regenerative Medicine and Stem Cell Therapy Field as it Transitions into the Clinic
  

Clinical Practicum on Day 2 Late Afternoon After Conclusion of Main Conference Presentations:

Offers Delegates Hands-on View of Adipose-derived Stem Cell Harvest, Generation of the SVF, and Demonstration of Tools and Technologies Utilized by Clinicians (Will be Hosted by Local Surgery Center and Performed by Licensed Clinicians in Full Compliance with Relevant Regulations).

All content presented in this conference as well as procedures presented in the Clinical Practicum are in compliance with applicable laws and regulations as set forth in the United States.